UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 189

Sortiert nach

Emicizumab for the treatment of acquired hemophilia A

Blood, 2021-01, Vol.137 (3), p.410-419

2021

Volltextzugriff (PDF)

Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia

Blood, 2014-06, Vol.123 (25), p.3951-3962

2014

Volltextzugriff (PDF)

Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes

Journal of allergy and clinical immunology, 2012-09, Vol.130 (3), p.607-612.e9

2012

Volltextzugriff (PDF)

Digital PCR: A Sensitive and Precise Method for KIT D816V Quantification in Mastocytosis

Clinical chemistry (Baltimore, Md.), 2018-03, Vol.64 (3), p.547-555

2018

Volltextzugriff (PDF)

Molecular quantification of tissue disease burden is a new biomarker and independent predictor of survival in mastocytosis

Haematologica (Roma), 2020-02, Vol.105 (2), p.366

2020

Volltextzugriff (PDF)

Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice

Haematologica (Roma), 2016-10, Vol.101 (10), p.1133

2016

Volltextzugriff (PDF)

Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML

Clinical cancer research, 2016-04, Vol.22 (8), p.2051-2061

2016

Volltextzugriff (PDF)

Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience

Haematologica (Roma), 2011-02, Vol.96 (2), p.231-237

2011

Volltextzugriff (PDF)

The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis

Haematologica (Roma), 2018-05, Vol.103 (5), p.799

2018

Volltextzugriff (PDF)

A Recombinant Hypoallergenic Parvalbumin Mutant for Immunotherapy of IgE-Mediated Fish Allergy

Journal of Immunology, 2007-05, Vol.178 (10), p.6290-6296

2007

Volltextzugriff (PDF)

Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non–mast cell hematopoietic neoplasms

Journal of allergy and clinical immunology, 2004-07, Vol.114 (1), p.3-11

2004

Volltextzugriff (PDF)

Recombinant Carp Parvalbumin, the Major Cross-Reactive Fish Allergen: A Tool for Diagnosis and Therapy of Fish Allergy

The Journal of immunology (1950), 2002-05, Vol.168 (9), p.4576-4584

2002

Volltextzugriff (PDF)

Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia

Haematologica (Roma), 2012-02, Vol.97 (2), p.246-250

2012

Volltextzugriff (PDF)

The pan-Bcl-2 blocker obatoclax promotes the expression of Puma, Noxa, and Bim mRNA and induces apoptosis in neoplastic mast cells

Journal of leukocyte biology, 2014-01, Vol.95 (1), p.95-104

2014

Volltextzugriff (PDF)

CD34+/CD38− stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin

Haematologica (Roma), 2012-02, Vol.97 (2), p.219-226

2012

Volltextzugriff (PDF)

How I treat patients with advanced systemic mastocytosis

Blood, 2010-12, Vol.116 (26), p.5812-5817

2010

Volltextzugriff (PDF)

Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia

Cancer research (Chicago, Ill.), 2004-05, Vol.64 (9), p.3148-3154

2004

Volltextzugriff (PDF)

Rituximab for the treatment of acquired antibodies to factor VIII

Haematologica (Roma), 2007-01, Vol.92 (1), p.66-71

2007

Volltextzugriff (PDF)

Neoplastic stem cells: A novel therapeutic target in clinical oncology

Cancer, 2006-11, Vol.107 (10), p.2512-2520

2006

Volltextzugriff (PDF)

Unique Effects of KIT D816V in BaF3 Cells: Induction of Cluster Formation, Histamine Synthesis, and Early Mast Cell Differentiation Antigens

The Journal of immunology (1950), 2008-04, Vol.180 (8), p.5466-5476

2008

Volltextzugriff (PDF)

Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy

Blood, 2018-08, Vol.132 (7), p.694-706

2018

Volltextzugriff (PDF)

DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling

Nature medicine, 2016-12, Vol.22 (12), p.1488-1495

2016

Volltextzugriff (PDF)

MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis

Journal of clinical oncology, 2019-11, Vol.37 (31), p.JCO1900640-2856

2019

Volltextzugriff (PDF)

1 – 25 von 189

Suche als RSS-Feed

Aktive Filter

KollektionStandalone journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(186)
Mit Volltextzugriff
(181)

Publikationsform

Artikel
(189)

Sprache

Englisch
(189)
Japanisch
(35)

Erscheinungsjahr

n.n

Thema

Science & Technology
(91)
Life Sciences & Biomedicine
(89)
Humans
(85)
Biological And Medical Sciences
(37)
Immunology
(37)
Hematology
(36)
Male
(36)
Female
(35)
Medical Sciences
(34)
Middle Aged
(34)
Adult
(30)
Aged
(30)
Animals
(23)
Hematologic And Hematopoietic Diseases
(23)
Allergens - Immunology
(22)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(20)
Aged, 80 And Over
(19)
Allergy
(17)
Plant Proteins - Immunology
(15)
Adolescent
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Emicizumab for the treatment of acquired hemophilia A

Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia

Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes

Digital PCR: A Sensitive and Precise Method for KIT D816V Quantification in Mastocytosis

Molecular quantification of tissue disease burden is a new biomarker and independent predictor of survival in mastocytosis

Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice

Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML

Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience

The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis

A Recombinant Hypoallergenic Parvalbumin Mutant for Immunotherapy of IgE-Mediated Fish Allergy

Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non–mast cell hematopoietic neoplasms

Recombinant Carp Parvalbumin, the Major Cross-Reactive Fish Allergen: A Tool for Diagnosis and Therapy of Fish Allergy

Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia

Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis

The pan-Bcl-2 blocker obatoclax promotes the expression of Puma, Noxa, and Bim mRNA and induces apoptosis in neoplastic mast cells

CD34+/CD38− stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin

How I treat patients with advanced systemic mastocytosis

Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

Rituximab for the treatment of acquired antibodies to factor VIII

Neoplastic stem cells: A novel therapeutic target in clinical oncology

Unique Effects of KIT D816V in BaF3 Cells: Induction of Cluster Formation, Histamine Synthesis, and Early Mast Cell Differentiation Antigens

Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy

DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling

MARS: Mutation-Adjusted Risk Score for Advanced Systemic Mastocytosis

Aktive Filter

Suchergebnisse filtern